Daré Bioscience (NASDAQ:DARE) Share Price Passes Below 200 Day Moving Average of $4.67

Shares of Daré Bioscience, Inc. (NASDAQ:DARE) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $4.67 and traded as low as $3.32. Daré Bioscience shares last traded at $3.32, with a volume of 18,820 shares changing hands.

Wall Street Analysts Forecast Growth

DARE has been the topic of a number of analyst reports. HC Wainwright reissued a “buy” rating and set a $72.00 target price on shares of Daré Bioscience in a report on Wednesday, May 15th. Brookline Capital Management raised shares of Daré Bioscience from a “hold” rating to a “buy” rating and set a $36.00 price target on the stock in a report on Wednesday, May 15th.

Daré Bioscience Price Performance

The stock has a market cap of $27.95 million, a P/E ratio of -0.86 and a beta of 1.37. The firm’s fifty day moving average price is $4.31 and its two-hundred day moving average price is $4.67.

Daré Bioscience (NASDAQ:DARE) last released its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($0.84) earnings per share for the quarter, missing the consensus estimate of ($0.72) by ($0.12). The firm had revenue of $0.01 million for the quarter, compared to analysts’ expectations of $0.52 million. During the same quarter in the prior year, the firm posted ($1.08) earnings per share. On average, research analysts expect that Daré Bioscience, Inc. will post -2.57 earnings per share for the current fiscal year.

About Daré Bioscience

Daré Bioscience, Inc, a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older.